» Articles » PMID: 30991723

Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Apr 18
PMID 30991723
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies leverage on their unique architecture to bind with an array of antigens. The strength of interaction has a direct relation to the affinity of the antibodies towards the antigen. affinity maturation is performed through multiple rounds of somatic hypermutation and selection in the germinal centre. This unique process involves intricate sequence rearrangements at the gene level via molecular mechanisms. The emergence of display technologies, mainly phage display and recombinant DNA technology, has helped revolutionize the way antibody improvements are being carried out in the laboratory. The adaptation of molecular approaches to replicate the processes has allowed for improvements in the way recombinant antibodies are designed and tuned. Combinatorial libraries, consisting of a myriad of possible antibodies, are capable of replicating the diversity of the natural human antibody repertoire. The isolation of target-specific antibodies with specific affinity characteristics can also be accomplished through modification of stringent protocols. Despite the ability to screen and select for high-affinity binders, some 'fine tuning' may be required to enhance antibody binding in terms of its affinity. This review will provide a brief account of phage display technology used for antibody generation followed by a summary of different combinatorial library characteristics. The review will focus on available strategies, which include molecular approaches, next generation sequencing, and approaches used for antibody affinity maturation in both therapeutic and diagnostic applications.

Citing Articles

FASTIA: A rapid and accessible platform for protein variant interaction analysis demonstrated with a single-domain antibody.

Matsunaga R, Tsumoto K Protein Sci. 2025; 34(3):e70065.

PMID: 39981938 PMC: 11843469. DOI: 10.1002/pro.70065.


Quantifying antibody binding: techniques and therapeutic implications.

Lodge J, Kajtar L, Duxbury R, Hall D, Burley G, Cordy J MAbs. 2025; 17(1):2459795.

PMID: 39957177 PMC: 11834528. DOI: 10.1080/19420862.2025.2459795.


Development and experimental validation of computational methods for human antibody affinity enhancement.

Li J, Liao L, Zhang C, Huang K, Zhang P, Zhang J Brief Bioinform. 2024; 25(6).

PMID: 39358035 PMC: 11446602. DOI: 10.1093/bib/bbae488.


Design and Production of a Novel Anti-PD-1 Nanobody by CDR Grafting and Site-Directed Mutagenesis Approach.

Mirzaei M, Mirhoseini S, Heidari M, Khatami M Mol Biotechnol. 2024; .

PMID: 38736021 DOI: 10.1007/s12033-024-01162-1.


Display of Lignin Peroxidase on the Surface of Bacillus subtilis.

Li S, He L, Shi N, Ni Z, Bu Q, Zhu D Appl Biochem Biotechnol. 2024; 196(10):6849-6863.

PMID: 38411933 DOI: 10.1007/s12010-024-04869-8.


References
1.
Griffiths A, Duncan A . Strategies for selection of antibodies by phage display. Curr Opin Biotechnol. 1998; 9(1):102-8. DOI: 10.1016/s0958-1669(98)80092-x. View

2.
Stemmer W . DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci U S A. 1994; 91(22):10747-51. PMC: 45099. DOI: 10.1073/pnas.91.22.10747. View

3.
Zoller M, Smith M . Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. DNA. 1984; 3(6):479-88. DOI: 10.1089/dna.1.1984.3.479. View

4.
Beerli R, Rader C . Mining human antibody repertoires. MAbs. 2010; 2(4):365-78. PMC: 3180084. DOI: 10.4161/mabs.12187. View

5.
Winter G, Milstein C . Man-made antibodies. Nature. 1991; 349(6307):293-9. DOI: 10.1038/349293a0. View